Malondialdehyde-modified low-density lipoprotein is a predictor of cardiac events in patients with stable angina on lipid-lowering therapy after percutaneous coronary intervention using drug-eluting stent

Details 詳細情報について

• CRID

  1363670318791220352

• DOI

  10.1016/j.atherosclerosis.2015.01.026

• ISSN

  00219150

• Web Site

  https://api.elsevier.com/content/article/PII:S002191501500060X?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S002191501500060X?httpAccept=text/plain

• Data Source

  • Crossref